CVS Health will pay $37.76 million to settle allegations it dispensed too many insulin pens to patients, and then obtained ...

Rising Diabetes Rates and Digital InnovatioFuel European Insulin Pen Market Growth European Insulin Pen Market European ...

The "U.S. Insulin Pen Market Opportunity, Growth Drivers, Industry Trend Analysis, and Forecast 2025-2034" report has been ...

Adults with type 1 diabetes using a continuous glucose monitoring system with a smart insulin pen attained a higher time in range if they responded more frequently to alerts for missed doses or high ...

Getting to grips with rising diabetes rates is arguably one of the most urgent tasks for South Africa's public healthcare system, but the setbacks keep coming. While some communities are facing ...

The "U.S. Insulin Delivery Devices Market Opportunity, Growth Drivers, Industry Trend Analysis, and Forecast 2025-2034" ...

CVS will pay for dispensing and billing health care plans including Tricare for more insulin than was prescribed, according to a lawsuit settlement.

For a decade, CVS knew it was skirting rules meant to limit overprescribing but did nothing to stop, according to the ...

The partnership is the first time Medtronic has integrated its insulin pumps with a sensor developed outside of the company.

The success of semaglutide and tirzepatide is evident in their 2024 sales volumes and revenues, creating a clearer picture of ...